Please assess the completion status of the following clinical trial:

Trial Title: BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Overweight and/or obese men and women with a body mass index (BMI) 30 to 45 kg/m2 with or without a comorbid condition (e.g., hypertension, dyslipidemia, CV disease, glucose intolerance, sleep apnea), or 27 to 29.9 kg/m2 with at least one comorbid condition.~* Ability to complete a 1 year study~Exclusion Criteria:~* Pregnancy~* Diabetes mellitus (type I, II or other)~* History of symptomatic heart valve disease~* Serious or unstable current or past medical conditions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Lorcaserin 10 mg QD (Type: EXPERIMENTAL): Lorcaserin 10 mg tablet each morning and placebo tablet each evening
- Lorcaserin 10 mg BID (Type: EXPERIMENTAL): Lorcaserin 10 mg tablet each morning and evening
- Matching Placebo (Type: PLACEBO_COMPARATOR): Matching placebo tablet each morning and evening

Based on this trial design, predict the completion outcome and termination type (if applicable).